MAPAL

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

🇦🇺 ASX

👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Microba Life Sciences Limited - Ordinary Fully Paid Deferred

📈 Performance

Price History

N/A

1M

All Time

Graph

Table

empty share chartempty share line

Performance graph isn't available yet for this share

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in MAPAL

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in MAPAL

N/A
MAPAL investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in MAPAL also invest in...

Want more shares? Try these...

Macquarie Technology Group Limited

MAQ

Macquarie Technology Group Ltd. engages in the provision of telecom and hosting services. The company is headquartered in Sydney, New South Wales and currently employs 470 full-time employees. The firm is engaged in the provision of telecommunication, cloud computing, cybersecurity and data center services to corporate and government customers within Australia. The firm operates through three segments: Cloud Services and Government, Data Centres and Telecom. The Cloud Services & Government segment is engaged in the provision of services utilizing the Company and its subsidiaries’ data center facilities to provide cybersecurity, colocation services, public and private cloud and storage to corporate and government customers. The Data Centres segment is engaged in the provision of services utilizing the Company and its subsidiaries’ data center facilities to wholesale customers. The Telecom segment is engaged in the provision of voice and mobile telecommunications services and the provision of services utilizing the Company and its subsidiaries’ data network.

🙌 Performance (5Yr p.a)

36.92%

📊 Share price

$68.33 AUD

📈 HIGH PRICE GROWTH

🤖 TECHNOLOGY

Find Out More

Microba Life Sciences Ltd. analyzes the microbiome to discover novel therapeutics and develop new diagnostic tools. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm is engaged in the discovery and development of therapeutics for major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. The company is engaged in providing microbiome testing, supplements and analysis services as well as developing new pathology services, therapeutics and diagnostics based on the human gut microbiome. The company offers various platforms, such as Analysis, Discovery, and Therapeutic. Its Analysis platform is an end-to-end solution for microbiome analysis. Using advanced metagenomic sequencing technology and proprietary bioinformatic tools, it provides precise and comprehensive measurement of the human gut microbiome. Its Discovery Platform is a global databank for microbiome discovery and develops new health solutions from the gut microbiome. Its Therapeutic platform is a repeatable platform for microbial therapeutic leads.

📊 Share price

$0.20 AUD

🩺 HEALTH CARE